Posted on 12月 8, 202312/8/23
From Strategy to Launch, EVERSANA’s Regulatory Consulting Helps European Pharma Achieve U.S. Approval
Posted on 12月 8, 202312/8/23
How a Start-Up Developing an Innovative AI-Enabled Imaging Device Achieved FDA Clearance in 24 Months
Posted on 12月 8, 202312/8/23
Early-Stage Pharmaceutical Company Overcomes Development Hurdles with Expert Clinical and CMC Regulatory Support
Posted on 10月 20, 202310/20/23
Leveraging QMS and Regulatory Expertise to Support Tissue Compliance
Posted on 10月 20, 202310/20/23
Responding to FDA Orders to Cease Manufacturing
Posted on 10月 3, 202310/3/23
Robust Signal Management to Achieve Patient Safety-Signal Case Study
Posted on 10月 3, 202310/3/23
Successful Implementation of End-To-End Pharmacovigilance Services For Drug-Device Combination Product Portfolio
Posted on 10月 3, 202310/3/23